Clinical Trials Directory

Trials / Completed

CompletedNCT04416061

The Role of a Private Hospital in Hong Kong Amid COVID-19 Pandemic

The Role of a Private Hospital in Hong Kong Amid COVID-19 Pandemic: A Descriptive Study of Patients With SARS-CoV-2 RT-PCR Performed

Status
Completed
Phase
Study type
Observational
Enrollment
2,510 (actual)
Sponsor
Hong Kong Sanatorium & Hospital · Industry
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Hong Kong public healthcare system is facing tremendous pressure under the COVID-19 pandemic. As the virus spread in Hong Kong, Hong Kong Sanatorium \& Hospital (HKSH) is one of the first private hospitals which immediately provide reliable and rapid COVID-19 test -- Reverse Transcription Polymerase Chain Reaction (RT-PCR). Early provision of the RT-PCR screening test for COVID-19 not only facilitates identification of COVID-19 but also contains the spread of the virus in the community and frontline medical staff. Since description of role of private hospital in Hong Kong amid COVID-19 pandemic is lacking, this study will describe COVID-19 screening algorithm and methodology. A retrospective analysis on clinical characteristics, laboratory findings as well as outcome of patients who underwent COVID-19 test in HKSH is also performed.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTCOVID 19 Diagnostic TestCOVID 19 Diagnostic Test

Timeline

Start date
2020-05-11
Primary completion
2020-07-31
Completion
2020-07-31
First posted
2020-06-04
Last updated
2024-02-28

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT04416061. Inclusion in this directory is not an endorsement.